Entrinsic Bioscience Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $49M

  • Investors
  • 9

Entrinsic Bioscience General Information

Description

Developer of a bio-mapping and electrophysiology platform designed to discover novel biocatalysts with transformational health benefits. The company's platform harnesses the body's own communication and natural protein regulation system to selectively modulate proteins, enabling patients to get relief from the side effects caused by chemotherapy or radiation therapy.

Contact Information

Formerly Known As
Entrinsic Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 500 River Ridge Drive
  • Suite 100
  • Norwood, MA 02063
  • United States
+1 (781) 000-0000

Entrinsic Bioscience Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Entrinsic Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series B1) 07-Jun-2021 $49M 00000 Completed Generating Revenue
10. Debt - General 30-Apr-2021 0000 000.00 Completed Generating Revenue
9. Secondary Transaction - Private 000.00 Completed Generating Revenue
8. Later Stage VC (Series B1) 19-Mar-2019 000.00 000.00 0000 Completed Generating Revenue
7. Accelerator/Incubator 01-Mar-2019 000.00 Completed Generating Revenue
6. Accelerator/Incubator 000.00 Completed
5. Early Stage VC (Series B) 04-Mar-2016 00.00 000.00 000.00 Completed
4. Early Stage VC (Series A) 31-Jan-2015 00.000 00.000 000.00 Completed
3. Grant $40M Completed
2. Grant 01-Jan-2015 $500K Completed
To view Entrinsic Bioscience’s complete valuation and funding history, request access »

Entrinsic Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A 7,413,780 $0.000100 $0.06 $0.69 $0.69 1x $0.69 10.73%
To view Entrinsic Bioscience’s complete cap table history, request access »

Entrinsic Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bio-mapping and electrophysiology platform designed to discover novel biocatalysts with transformational
Biotechnology
Norwood, MA
32 As of 2023
00000
00000000000 00000

000000

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000000000000
Saint Louis, MO
000000&0

000000

is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fu
0000 000000000
Watertown, MA
00 As of 0000
00000
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Entrinsic Bioscience Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biosynthema Corporate Backed or Acquired Saint Louis, MO 000000&0
Selecta Biosciences Formerly VC-backed Watertown, MA 00 00000 000000&0 00000
Genentech Formerly VC-backed South San Francisco, CA 00000 00.000 00000000000 00.000
Blueprint Medicines Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
Abbiotec Corporation Escondido, CA 0
You’re viewing 5 of 38 competitors. Get the full list »

Entrinsic Bioscience Executive Team (19)

Name Title Board Seat Contact Info
Stephen Gatto Chief Executive Officer and Chairman
Daniel Dennison Ph.D Chief Technology Officer & Board Member
Steve Cohen Chief Marketing Officer
Nathan Fagre Executive Vice President, CAO & General Counsel
Henry Binder MD Advisory Board Member
You’re viewing 5 of 19 executive team members. Get the full list »

Entrinsic Bioscience Board Members (10)

Name Representing Role Since
Brian Fox Self Board Member 000 0000
Charlotte Hubbert Ph.D Self Board Member 000 0000
Daniel Dennison Ph.D Entrinsic Bioscience Chief Technology Officer & Board Member 000 0000
Dennis Crowley Self Board Member 000 0000
Robert Coughlin Massachusetts Biotechnology Education Foundation Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Entrinsic Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entrinsic Bioscience Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
MassCONNECT Accelerator/Incubator Minority 000 0000 000000 0
Johnson & Johnson Corporation Minority 000 0000 000000 0
Junonia Capital, LLC Venture Capital Minority 000 0000 000000 0
Enterade Investment Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Entrinsic Bioscience FAQs

  • When was Entrinsic Bioscience founded?

    Entrinsic Bioscience was founded in 2011.

  • Who is the founder of Entrinsic Bioscience?

    Sadasivan Vidyasagar Ph.D is the founder of Entrinsic Bioscience.

  • Who is the CEO of Entrinsic Bioscience?

    Stephen Gatto is the CEO of Entrinsic Bioscience.

  • Where is Entrinsic Bioscience headquartered?

    Entrinsic Bioscience is headquartered in Norwood, MA.

  • What is the size of Entrinsic Bioscience?

    Entrinsic Bioscience has 32 total employees.

  • What industry is Entrinsic Bioscience in?

    Entrinsic Bioscience’s primary industry is Biotechnology.

  • Is Entrinsic Bioscience a private or public company?

    Entrinsic Bioscience is a Private company.

  • What is Entrinsic Bioscience’s current revenue?

    The current revenue for Entrinsic Bioscience is 000000.

  • How much funding has Entrinsic Bioscience raised over time?

    Entrinsic Bioscience has raised $122M.

  • Who are Entrinsic Bioscience’s investors?

    Johnson & Johnson Innovation - JJDC, MassCONNECT, Johnson & Johnson, Junonia Capital, LLC, and Enterade Investment Partners are 5 of 9 investors who have invested in Entrinsic Bioscience.

  • Who are Entrinsic Bioscience’s competitors?

    Biosynthema, Selecta Biosciences, Genentech, Blueprint Medicines, and Abbiotec are some of the 38 competitors of Entrinsic Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »